S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Ibio Inc [IBIO]

Exchange: AMEX Industry: Biotechnology
Last Updated17 May 2024 @ 16:00

9.39% $ 1.980

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States...

Stats
Today's Volume 326 072
Average Volume 3.86M
Market Cap 17.07M
EPS $0 ( 2024-05-13 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.130
ATR14 $0.0120 (0.61%)
Insider Trading
Date Person Action Amount type
2024-05-09 Brenner Martin Buy 147 300 Stock Option (right to buy)
2024-05-09 Brenner Martin Buy 110 000 Stock Option (right to buy)
2024-05-09 Duran Felipe Buy 90 000 Stock Option (right to buy)
2024-04-25 Duran Felipe Buy 35 800 Stock Option (right to buy)
2023-11-01 Brenner Martin Sell 4 881 Common Stock
INSIDER POWER
88.07
Last 90 transactions
Buy: 50 268 524 | Sell: 29 398 433

Volume Correlation

Long: 0.10 (neutral)
Short: -0.63 (weak negative)
Signal:(37.733) Neutral

Ibio Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ibio Inc Correlation - Currency/Commodity

The country flag -0.76
( moderate negative )
The country flag 0.73
( moderate )
The country flag 0.00
( neutral )
The country flag -0.76
( moderate negative )
The country flag -0.61
( weak negative )

Ibio Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-1.11M (0.00 %)
EPS: $-47.87
FY 2023
Revenue: $0
Gross Profit: $-1.11M (0.00 %)
EPS: $-47.87
FY 2022
Revenue: $2.38M
Gross Profit: $2.17M (90.94 %)
EPS: $-2 924.26
FY 2021
Revenue: $2.37M
Gross Profit: $909 000 (38.34 %)
EPS: $-2.97

Financial Reports:

No articles found.

Ibio Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ibio Inc

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators